Drug Trial Radar · NCT04363801
A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer
Last checked: Nov 19, 2026Latest source record: Oct 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
247
Actual
Start
Jul 29, 2020
Primary completion
Mar 31, 2025
Study completion Mar 31, 2025
Sponsor
- Lead sponsor
- Leap Therapeutics, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- BeiGene
- First posted
- Apr 27, 2020
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination with Tislelizumab ± Chemotherapy as First-Line or Second-Line Therapy in Adult Patients with Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Conditions
- Gastric Cancer
- Gastric Adenocarcinoma
- GastroEsophageal Cancer
Interventions
DKN-01 300mgDrug
Administered by IV infusion
DKN-01 600mgDrug
Administered by IV infusion
DKN-01 400mgDrug
Administered by IV infusion
Tislelizumab 200mgDrug
Administered by IV infusion
Tislelizumab 400mgDrug
Administered by IV infusion
OxaliplatinDrug
Administered by IV infusion
Capecitabine 1000mg/ m2 twice daily (BID)Drug
Administered orally
Leucovorin CalciumDrug
Administered by IV infusion
FluorouracilDrug
Administered by IV infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A and B: Safety and Tolerability of DKN-01 in G/GEJ PatientsTime frame: approximately 28 months
- Part C: Progression Free Survival (PFS) in G/GEJ DKK1 High and Overall Patients Treated With DKN-01 in Combination With Tislelizumab and Chemotherapy vs Tislelizumab and Chemotherapy as a First-line TherapyTime frame: approximately 30 months
Locations
48 sites in 3 countries. Site status is shown where the registry gives one.
Mayo Clinic Cancer Center
Phoenix, Arizona
University of Arizona
Tucson, Arizona
City of Hope
Duarte, California
The Angeles Clinic Research Institute - A Cedars-Sinai Affiliate
Los Angeles, California
University of Southern California
Los Angeles, California
UCLA
Los Angeles, California
Hoag Memorial Hospital Presbyterian
Newport Beach, California
Chao Family Comprehensive Cancer Center, University of California, Irvine
Orange, California
University of California San Francisco
San Francisco, California
Mayo Clinic Florida
Jacksonville, Florida
AdventHealth Cancer Institute
Orlando, Florida
Northwestern University Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois
University of Chicago
Chicago, Illinois
Pontchartrain Cancer Center
Covington, Louisiana
Massachusetts General Hospital
Boston, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Dana-Farber Cancer Institute
Boston, Massachusetts
Columbia University Irving Medical Center
New York, New York
Duke University Medical Center
Durham, North Carolina
Fox Chase Cancer Center
Philadelphia, Pennsylvania
Rhode Island Hospital
Providence, Rhode Island
MD Anderson Cancer Center
Houston, Texas
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin
Charité Universitätsmedizin Berlin
Berlin, Germany
Institut Fur Klinisch Onkologische Forschung Am Krankenhaus Nordwest
Frankfurt, Germany
Hämatologisch-Onkologische Praxis Eppendorf (HOPE)
Hamburg, Germany
Universitatsklinikum Heidelberg
Heidelberg, Germany
Slk-Kliniken
Heilbronn, Germany
Studienzentrum Onkologie Ravensburg
Ravensburg, Germany
Caritas Klinikum Saarbrücken St. Theresia
Saarbrücken, Germany
Korea University Ansan Hospital
Ansan-si, South Korea
Hallym University Sacred Heart Hospital
Anyang, South Korea
Dong-A University Hospital
Busan, South Korea
National Cancer Center
Goyang, South Korea
Gachon University Gil Medical Center
Incheon, South Korea
Inha University Hospital
Incheon, South Korea
Seoul National University Bundang Hospital
Seongnam, South Korea
Korea University Anam Hospital
Seoul, South Korea
Hanyang University Hospital
Seoul, South Korea
Asan Medical Center
Seoul, South Korea
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.